$CINGW
Cingulate Inc.
Nasdaq · Pharmaceutical Preparations · Kansas City, KS
CINGW chart
What traders are saying about $CINGW
Latest postsCingulate Inc. news
- Attention Deficit Hyperactivity Disorder Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Afecta Pharma, ABVC BioPharma, Mind Medicine, Neurocentria
StreetInsider ·
- New Research Finds Daily Peanut Consumption Benefits Brain's Response to Insulin in Memory Related Regions
Eastern Progress ·
- Scientists Discover That Eating Peanuts Every Day May Help Protect the Aging Brain
SciTechDaily ·
- Distinct Calcium Response Signatures Separate Itch and Pain in Brain Neurons
Bioengineer.org ·
- How Autism Reduces Sensitivity to Decision Feedback
Mirage News ·
- Cingulate Inc. Estimates – NASDAQ:CINGW
TradingView ·
- Does It Look Painful or Disgusting? Ask Your Parietal and Cingulate Cortex
Journal of Neuroscience ·
- Early-life pain led to lasting social deficits in mice, and brain stimulation reversed them
PsyPost ·
- Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Yahoo Finance ·
- CING: Second Quarter Results
Yahoo Finance ·
- Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Yahoo Finance ·
- Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Yahoo Finance ·
Cingulate Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$22.4M | -$16.6M | -$23.5M | -$17.7M |
| Diluted EPS | $-4.44 | $-10.86 | $-311.99 | $-29.35 |
| Total assets (year end) | $15.1M | $14.9M | $3.5M | $11.4M |
| Cash and equivalents (year end) | $11.0M | $12.2M | $52,416 | $5.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cingulate Inc.
- Ticker
- CINGW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Kansas City, KS
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1862150
- Former names
- Cingulate Inc.
Frequently asked questions
What exchange is Cingulate Inc. listed on?
Cingulate Inc. trades on the Nasdaq under the ticker symbol CINGW.
What industry is Cingulate Inc. in?
Cingulate Inc. is classified by the SEC under "Pharmaceutical Preparations".
Where is Cingulate Inc. headquartered?
Cingulate Inc.'s business address on file with the SEC is in Kansas City, KS.
When does Cingulate Inc.'s fiscal year end?
Cingulate Inc.'s fiscal year ends on December 31.